Document Detail


Forced-air warming decreases vasodilator requirement after coronary artery bypass surgery.
MedLine Citation:
PMID:  10648308     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Postoperative hypothermia is common and associated with adverse hemodynamic consequences, including adrenergically mediated systemic vasoconstriction and hypertension. Hypothermia is also a known predictor of dysrhythmias and myocardial ischemia in high-risk patients. We describe a prospective, randomized trial designed to test the hypothesis that forced-air warming (FAW) provides improved hemodynamic variables after coronary artery bypass graft. After institutional review board approval and written informed consent, 149 patients undergoing coronary artery bypass graft were randomized to receive postoperative warming with either FAW (n = 81) or a circulating water mattress (n = 68). Core temperature was measured at the tympanic membrane. A weighted mean skin temperature was calculated. Heart rate, mean arterial blood pressure, central venous pressure, cardiac output, and systemic vascular resistance were monitored for 22 h postoperatively. Mean arterial blood pressure was maintained by protocol between 70 and 80 mm Hg by titration of nitroglycerin and sodium nitroprusside. The two groups had similar demographic characteristics. Tympanic and mean skin temperatures were similar between groups on intensive care unit admission. During postoperative rewarming, tympanic temperature was similar between groups, but mean skin temperature was significantly greater in the FAW group (P < 0.05). Heart rate, mean arterial pressure, central venous pressure, cardiac output, and systemic vascular resistance were similar for the two groups. The percent of patients requiring nitroprusside to achieve the hemodynamic goals was less (P < 0.05) in the FAW group. In conclusion, aggressive cutaneous warming with FAW results in a higher mean skin temperature and a decreased requirement for vasodilator therapy in hypothermic patients after cardiac surgery. This most likely reflects attenuation of the adrenergic response or opening of cutaneous vascular beds as a result of surface warming. IMPLICATIONS Forced-air warming after cardiac surgery decreases the requirement for vasodilator drugs and may be beneficial in maintaining hemodynamic variables within predefined limits.
Authors:
H K El-Rahmany; S M Frank; G M Schneider; N A El-Gamal; C A Vannier; R Ammar; A S Okasha
Related Documents :
8817228 - Platelet activating factor antagonism improves cardiovascular function in non-hypotensi...
15101858 - Preoperative stellate ganglion blockade prevents tourniquet-induced hypertension during...
8452438 - Cardiopulmonary bypass and pulmonary thromboxane generation.
3935068 - Dissociation between cerebral autoregulation and carbon dioxide reactivity during nonpu...
12618568 - Can relaxation lower metaboreflex-mediated blood pressure elevations?
8779898 - Regulation of glomerular volume in normal and partially nephrectomized rats.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Anesthesia and analgesia     Volume:  90     ISSN:  0003-2999     ISO Abbreviation:  Anesth. Analg.     Publication Date:  2000 Feb 
Date Detail:
Created Date:  2000-02-28     Completed Date:  2000-02-28     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  1310650     Medline TA:  Anesth Analg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  286-91     Citation Subset:  AIM; IM    
Affiliation:
Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Anesthesia
Body Temperature
Coronary Artery Bypass*
Female
Hemodynamics / drug effects
Humans
Male
Middle Aged
Monitoring, Physiologic
Nitroglycerin / administration & dosage,  therapeutic use
Nitroprusside / administration & dosage,  therapeutic use
Postoperative Period
Prospective Studies
Rewarming / methods*
Vasodilator Agents / administration & dosage,  therapeutic use*
Chemical
Reg. No./Substance:
0/Vasodilator Agents; 15078-28-1/Nitroprusside; 55-63-0/Nitroglycerin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The use of esmolol, nicardipine, or their combination to blunt hemodynamic changes after laryngoscop...
Next Document:  Oral ketamine/midazolam is superior to intramuscular meperidine, promethazine, and chlorpromazine fo...